Additionally, iron dysregulation induced the decline of glutathione (GSH) and glutathione peroxidase 4 (GPX4) and ROS accumulation, and these factors together caused changes in AD markers such as amyloid beta peptide and Tau protein (Gleason and Bush, 2021). The gene discussed is MAPT; the disease is Alzheimer disease.